MGC Pharmaceuticals Ltd (ASX: MXC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

MGC Pharmaceuticals Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $17.98 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 43.85 million
Earnings per share -3.206
Dividend per share N/A
Year To Date Return -11.58%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • MGC Pharmaceuticals Ltd (ASX: MXC)
    Latest News

    Lab worker puts hands in the air and dances around
    Healthcare Shares

    The MGC Pharmaceuticals (ASX:MXC) share price soared 20% today. Here's why

    The cannabis company's shares finished the week on a high note...

    Read more »

    A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
    Healthcare Shares

    MGC Pharmaceuticals (ASX:MXC) share price climbs on study approval

    The Israeli Ministry of Health has approved a dosing study of a drug candidate. Here are the details

    Read more »

    A group of science or medical professionals cheering good news in the lab.
    Healthcare Shares

    Why the MGC Pharmaceuticals (ASX:MXC) share price is leaping 5%

    MGC Pharma shares are talking the talk today after a key update. Here's what we know.

    Read more »

    Falling cannabis asx share price represented by cannabis leaves on a declining line graph
    Share Market News

    What's going wrong for ASX cannabis shares lately?

    Why Aussie cannabis companies are worth watching right now...

    Read more »

    Cannabis from the earth in the hands
    Share Gainers

    MGC Pharma (ASX:MXC) share price jumps 11% on UK approval

    This cannabis share is smoking the market today...

    Read more »

    A businessman leaps in the air outside a city building in the CBD.
    Share Market News

    MGC Pharmaceuticals (ASX:MXC) share price rockets 40% on supply deal

    A new US supply and distribution deal has seen shares in the pharma company soar

    Read more »

    Three pills with faces showing sad to happy, indicating a rising share price for an ASX pharmaceutical company
    Healthcare Shares

    The MGC Pharmaceuticals (ASX:MXC) share price is on a roll today. Here's why

    The MGC Pharmaceuticals (ASX: MXC) share price is up 3.4% after the company shared news of a $1 million order.

    Read more »

    A graphic showing a rising share price in medical cannabis shares
    Share Gainers

    Why the MGC Pharma (ASX:MXC) share price has rocketed 9%

    The MGC Pharma Ltd (ASX: MGC) share price is rocketing higher amid a broader rebound and North American product update…

    Read more »

    The last piece of the jigsaw being fitted, indicating good news for a share price on merger or acquisition
    Healthcare Shares

    Why the MGC Pharmaceuticals (ASX:MXC) share price is up 5% today

    The MGC Pharmaceuticals (ASX: MXC) share price is soaring with news the company will acquire a clinical research company.

    Read more »

    cannabis leaves on a rising line graph representing growth of ASX cannabis share price
    Share Market News

    Why the MGC Pharma (ASX:MXC) share price is zooming 13% higher today

    The MGC Pharma (ASX: MXC) share price is up 13% in morning trade. We look at the latest from the…

    Read more »

    Young doctor raising arms in air with hands in fists celebrating a new development
    Share Market News

    Why the MGC Pharmaceuticals (ASX:MXC) share price is jumping 8%

    The MGC Pharmaceuticals (ASX:MXC) share price is surging after the company's drug was passed by two ethics committees. Here's the…

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Share Market News

    Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today

    The MGC Pharma share price is gaining today, up 3% in late morning trade. We take a look at what's…

    Read more »

    MXC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About MGC Pharmaceuticals Ltd

    MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.

    MXC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $0.41 $-0.01 -2.38% 9,618 $0.41 $0.41 $0.40
    27 Mar 2024 $0.42 $0.03 7.59% 13,088 $0.40 $0.42 $0.40
    26 Mar 2024 $0.40 $-0.02 -4.88% 38,947 $0.41 $0.41 $0.39
    25 Mar 2024 $0.41 $-0.03 -6.90% 1,435 $0.44 $0.44 $0.41
    22 Mar 2024 $0.44 $0.00 0.00% 2,710 $0.44 $0.44 $0.41
    21 Mar 2024 $0.44 $0.01 2.33% 25,204 $0.43 $0.44 $0.43
    20 Mar 2024 $0.43 $0.02 4.88% 11,514 $0.43 $0.43 $0.41
    19 Mar 2024 $0.41 $-0.01 -2.38% 43 $0.42 $0.42 $0.41
    18 Mar 2024 $0.42 $-0.02 -4.60% 1,040 $0.44 $0.44 $0.42
    15 Mar 2024 $0.44 $0.03 7.32% 5,114 $0.42 $0.44 $0.42
    14 Mar 2024 $0.41 $0.00 0.00% 10,067 $0.41 $0.43 $0.41
    13 Mar 2024 $0.41 $-0.01 -2.38% 86,359 $0.41 $0.42 $0.41
    12 Mar 2024 $0.42 $0.00 0.00% 102,188 $0.42 $0.42 $0.40
    11 Mar 2024 $0.42 $-0.01 -2.35% 17,054 $0.43 $0.43 $0.40
    08 Mar 2024 $0.43 $-0.01 -2.33% 65,674 $0.43 $0.43 $0.41
    07 Mar 2024 $0.43 $-0.02 -4.44% 6,201 $0.45 $0.45 $0.43
    06 Mar 2024 $0.45 $-0.05 -10.00% 86,357 $0.45 $0.45 $0.43
    05 Mar 2024 $0.50 $0.08 19.05% 133,054 $0.42 $0.50 $0.42
    04 Mar 2024 $0.42 $-0.03 -6.67% 36,052 $0.44 $0.50 $0.42
    01 Mar 2024 $0.45 $0.00 0.00% 60,235 $0.45 $0.45 $0.41
    29 Feb 2024 $0.45 $0.05 12.50% 13,116 $0.40 $0.45 $0.40
    28 Feb 2024 $0.40 $0.03 8.00% 19,552 $0.38 $0.40 $0.38
    27 Feb 2024 $0.38 $-0.04 -9.76% 16,733 $0.41 $0.41 $0.38

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 May 2023 Brett Mitchell Expiry 17,500,000 $157,500
    As advised by the company. 49,00,000 Performance Rights, As per announcement on 05-05-2023
    05 May 2023 Ross Walker Expiry 1,050,000 $9,450
    As advised by the company. Lapse of Performance Rights
    05 May 2023 Nativ Segev Expiry 1,050,000 $9,450
    As advised by the company. 600,000 Performance Rights, AS per announcement on 05-05-2023
    05 May 2023 Roby Zomer Expiry 17,500,000 $157,500
    As advised by the company. 49,00,000 Performance Rights, As per announcement on 05-05-2023
    05 May 2023 Stephen Parker Expiry 1,400,000 $12,600
    As advised by the company. Lapse of Performance Rights, As per announcement on 05-05-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Layton Patrick Mills Non-Executive Director Jun 2023
    Mr Mills is a life-sciences executive, having worked in the biotechnology and life sciences industries for over 15 years, developing experience across human and animal health in pharmaceutical and consumer healthcare.
    Mr Brett Anthony Mitchell Executive ChairmanExecutive Director Apr 2013
    Mr Mitchell has over 25 years of experience in the venture capital, equity capital markets, technology and resources sectors. He has been involved in the founding, financing and management of both private and publicly listed companies, and was instrumental in the successful LSE listing for MGC Pharma in February 2021.
    Mr Daniel Robinson Non-Executive Director Dec 2023
    Mr Robinson has 20 years experience in a range of corporate roles across stockbroking, corporate advisory, investor relations and governance. He is a Company Secretary and Director of both private and listed companies.
    Mr Nativ Segev Non-Executive Director Feb 2016
    Mr Segev has over 10 years of experience in implementation, legislation and lobbying in the global Medical Cannabis industry, combined with over 15 years of experience in diverse executive roles.
    Mr Roby Reuven Zomer Chief Executive OfficerManaging Director Feb 2016
    Mr Zomer was recruited into MGC Pharma by its founders at the inception of the company and has since served in multiple roles within the company, culminating with his current role as MD and CEO. With 11 years of experience in projects in the Biotech and Agrotech sectors, Mr Zomer has been necessary in moving MGC Pharma from a cannabis concept to a fully functioning biopharma company with global activities.
    Mr Messrs Rowan Harland Company Secretary Mar 2023
    -
    Messrs Rowan Harland Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Computershare Clearing Pty Ltd <Ccnl Di A/C> 1,416,661,256 31.99%
    Bioheka Limited 107,000,000 2.42%
    Citicorp Nominees Pty Limited 95,516,192 2.16%
    Orca Capital Gmbh 94,287,918 2.13%
    Hsbc Custody Nominees (Australia) Limited 93,845,701 2.12%
    BNP Paribas Nominees Pty Ltd Acf Clearstream 85,199,520 1.92%
    Mr Shachar Shimony 69,500,000 1.57%
    Mercer Street Global Opportunity Fund Llc 65,600,000 1.48%
    Sofia Even 51,000,000 1.15%
    Mr Michael Sean Newton 48,000,000 1.08%
    Chetcuti Holdings Pty Ltd 46,044,900 1.04%
    Mr George Bishay 36,822,890 0.83%
    Bnp Paribas Noms Pty Ltd <Drp> 36,108,923 0.82%
    Mrs Ilena Alemao 23,343,478 0.53%
    Mrs Yifat Steuer 17,193,146 0.39%
    Fairbrother Holdings Pty Ltd 16,043,478 0.36%
    Jep Pty Ltd <Jp Pension Fund A/C> 13,675,805 0.31%
    Ibi Trust Management <Nadya Lisovoder A/C> 13,372,365 0.31%
    Mr Gagandeep Singh 13,333,333 0.30%
    Mr Paul Merlo 13,043,488 0.29%

    Profile

    since

    Note